Cullinan Therapeutics News

JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $29

Moomoo NewsSep 25 08:33 ET

Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $36

Moomoo NewsSep 18 08:33 ET

BTIG Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsSep 18 07:31 ET

Cullinan Therapeutics Analyst Ratings

BenzingaSep 17 11:10 ET

TD Cowen Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating

Moomoo NewsSep 16 08:31 ET

Stifel Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsSep 16 08:31 ET

H.C. Wainwright Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $28

Moomoo NewsSep 16 06:31 ET

Cullinan Oncology Price Target Maintained With a $28.00/Share by HC Wainwright & Co.

Dow JonesSep 16 06:29 ET

JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $29

Moomoo NewsSep 14 15:31 ET

BTIG Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsSep 13 07:31 ET

JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $29

Moomoo NewsSep 9 08:31 ET

Cullinan Therapeutics Analyst Ratings

BenzingaAug 9 10:02 ET

Wedbush Reiterates Outperform on Cullinan Therapeutics, Maintains $36 Price Target

BenzingaAug 9 10:02 ET

Cullinan Therapeutics Analyst Ratings

BenzingaJun 3 06:11 ET

Cullinan Therapeutics Analyst Ratings

BenzingaMay 24 06:57 ET

HC Wainwright Adjusts Price Target on Cullinan Oncology to $28 From $29, Maintains Buy Rating

MT NewswiresMay 16 12:07 ET

Cullinan Therapeutics Analyst Ratings

BenzingaMay 16 08:27 ET

Cullinan Therapeutics Analyst Ratings

BenzingaMay 1 05:51 ET

Cullinan Oncology Analyst Ratings

BenzingaApr 17 12:04 ET

Cullinan Oncology Analyst Ratings

BenzingaApr 16 12:56 ET